Analysts expect over 2024 growing sales Novozymes

Tomorrow the Danish Novozymes will publish its past quarter figures. For this year the company from Bagsvaerd could earn a total revenue around 3.95 billion Danish Krone. This is according to the average of the analysts' estimates. The expected revenue would be a record for the company. This is quite more than 2023's revenue of 2.4 billion Danish Krone.

Historical revenues and results Novozymes plus estimates 2024

beursgrafiek

Novozymes Denmark ©

Novozymes
Novozymes


The analysts expect for 2024 a net profit of 610 million Danish Krone. For this year most of the analysts expect a profit per share of 1.29 Danish Krone. Based on this the price/earnings-ratio is a very high 310.85.

Per share the analysts anticipate on a dividend of 1.16 Danish Krone per share. The dividend yield is then 0.29 percent. The average dividend yield of the chemical companies equals an attractive 2.11 percent.

Based on the current number of shares Novozymes 's market capitalization equals 89.37 billion Danish Krone.

Historical stock prices Novozymes period 2007-2024

fundamental data novozymes

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.